CD40 and cancer: Hyperactive WNT/β-catenin signaling, often driven by APC loss, is a well-established pan-cancer mechanism for fostering an immune-excluded microenvironment by preventing T-cell infiltration [36, 37], providing a mechanistic basis for the observed low CD40 expression.